| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |